Robert Barrow

Director & Chief Executive Officer

Director & Chief Executive Officer at Definium Therapeutics, Inc., filing insider transactions between 2026-03-25 and 2026-06-25.

Total Purchases

—

0 transactions

Total Sales

$1.8M

2 transactions

Companies Traded

2 total filings

Active Since

2026-03-25

Last: 2026-06-25

Companies

Definium Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-06-25	DFTX	Sale	29.2K	$45.03	$1.3M	1.10M	SEC ↗
2026-03-25	DFTX	Sale	24.4K	$18.47	$451K	752.5K	SEC ↗